Drug intelligence / Profile preview

enituzumab + Abesili + anastrozole

Development stage
Unknown
Administration
Oral
01

Overview

Information on the drug combination "enituzumab + Abesili + anastrozole" was searched for based on the provided text. The search results provided information only on anastrozole, stating that no information was found for "enituzumab" or "Abesili" or the specific combination. Based on the text, anastrozole is an aromatase inhibitor medication primarily used to treat hormone receptor-positive breast cancer in postmenopausal women. It works by blocking the enzyme aromatase, which reduces estrogen production in the body. This helps slow or stop the growth of breast cancers that need estrogen to grow. The brand name for anastrozole is Arimidex, though there are other generic brands available. It's typically taken as a tablet once daily, with or without food, and treatment often continues for up to 5 years. Anastrozole is used in several contexts: * As adjuvant treatment for early-stage breast cancer to reduce risk of recurrence * For treatment of advanced or metastatic breast cancer * Sometimes to reduce breast cancer risk in high-risk postmenopausal women * Occasionally in men with breast cancer, though tamoxifen is more commonly used for men Common side effects of anastrozole include joint pain, hot flashes, weakness, mood changes, and bone loss that may increase fracture risk.

02

Targets

ESR1 (ERα)CYP19A1 (Aromatase)

Beyond the preview

Go deeper on enituzumab + Abesili + anastrozole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on enituzumab + Abesili + anastrozole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call